+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
18 Jul 2015

Valent Pharmaceutical acquired Egyptian Pharmaceutical company Amoun

  • Valeant Pharmaceuticals plans to expand its reach in the Middle East and North Africa after reaching a deal tvaleant_logoo buy an Egyptian pharmaceutical company for about US$800 million.
  • The Quebec-based company said it has a definite agreement to buy Amoun Pharmaceutical from Mercury (Cayman) Holdings.
    The deal includes Amoun’s manufacturing plant, which would add to Valeant’s 40 manufacturing plants around the world.
  • Egypt’s pharmaceutical industry is approximnately US$21 billion. This acquisition will help Valeant to have strong foothold in Egypt and other middle east countries.
  • Amoun has sales expected to reach about US$223 million this year. It has more than 30 branded products, including those for animal health and the treatment of hypertension, infections and diarrhea.


Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests